Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our top-notch dedicated system is used to design specialised libraries.
Fig. 1. The sreening workflow of Receptor.AI
Utilising molecular simulations, our approach thoroughly examines a wide array of proteins, tracking their conformational changes individually and within complexes. Ensemble virtual screening enables us to address conformational flexibility, revealing essential binding sites at functional regions and allosteric locations. Our rigorous analysis guarantees that no potential mechanism of action is overlooked, aiming to uncover new therapeutic targets and lead compounds across diverse biological functions.
Key features that set our library apart include:
partner
Reaxense
upacc
Q9NSY2
UPID:
STAR5_HUMAN
Alternative names:
START domain-containing protein 5
Alternative UPACC:
Q9NSY2; P59094
Background:
StAR-related lipid transfer protein 5, also known as START domain-containing protein 5, plays a crucial role in the intracellular transport of sterols and other lipids. Its ability to potentially bind cholesterol or other sterols suggests a significant function in cellular lipid metabolism and homeostasis.
Therapeutic significance:
Understanding the role of StAR-related lipid transfer protein 5 could open doors to potential therapeutic strategies. Its involvement in lipid transport and metabolism positions it as a key target for addressing disorders related to lipid imbalances.